ALIVIO THERAPEUTICS

alivio-therapeutics-logo

Alivio Therapeutics is pioneering targeted disease immunomodulation as a novel strategy to treat a range of chronic and acute inflammatory disorders. Targeted disease immunomodulation involves tuning the immune system exclusively at the site of disease in the body, with minimal impact on the rest of the immune system. This long sought-after approach has potential to treat a range of chronic and acute inflammatory disorders including ones that would otherwise be difficult to treat. Alivio has exc... lusive rights to a proprietary inflammation-targeting technology, based on the research of Dr. Karp (BWH/HMS) and Dr. Robert Langer (MIT), which is the first technology to reproducibly show the ability to target immunomodulatory compounds to inflamed tissue, which can lead to dramatic improvements in treatment efficacy with major reductions in systemic effects. The platform has been validated in multiple labs and preclinical models of inflammation, including models where the inflammation occurred in different parts of the body (e.g., the GI system, the bladder, joints, skin, etc.). The technology could potentially be used with a variety of medications (e.g., small molecules, biologics, and nucleic acids) both independently or in combination, and is designed to be administered orally or via other routes. With this platform, Alivio aims to address the dozens of conditions where inflammation is a central part of the underlying disease pathology, but where targeted and effective treatment options are lacking.

#SimilarOrganizations #People #Financial #Website #More

ALIVIO THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2016-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.aliviotherapeutics.com

Total Employee:
11+

Status:
Active

Total Funding:
3.3 M USD

Technology used in webpage:
Euro Canadian Server Location


Similar Organizations

edison-pharmaceuticals-logo

Edison Pharmaceuticals

Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.

interline-therapeutics-logo

Interline Therapeutics

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.


Current Advisors List

harry-leider_image

Harry Leider Board Member @ Alivio Therapeutics
Board_member
2020-01-01

Current Employees Featured

jeff-karp_image

Jeff Karp
Jeff Karp Co-Founder, Scientific Advisory Board Member, and Board Observer @ Alivio Therapeutics
Co-Founder, Scientific Advisory Board Member, and Board Observer
2016-05-01

Founder


jeff-karp_image

Jeff Karp

Investors List

u-s-department-of-defense_image

U.S. Department of Defense

U.S. Department of Defense investment in Grant - Alivio Therapeutics

Official Site Inspections

http://www.aliviotherapeutics.com

  • Host name: 172.67.202.124
  • IP address: 172.67.202.124
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Alivio Therapeutics"

Alivio Therapeutics - Crunchbase Company Profile & Funding

Alivio Therapeutics is pioneering targeted disease immunomodulation as a novel strategy to treat a range of chronic and acute inflammatory disorders.See details»

Alivio Therapeutics 2025 Company Profile: Valuation, Funding ...

Information on valuation, funding, cap tables, investors, and executives for Alivio Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

ALIVIO THERAPEUTICS, INC. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for ALIVIO THERAPEUTICS, INC. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»

Alivio Therapeutics - VentureRadar

"Alivio is pioneering a novel strategy to treat inflammatory diseases based on modulating the immune system at the site of disease. Alivio is developing a proprietary platform centered on a โ€ฆSee details»

Alivio Therapeutics - 2025 Company Profile - Tracxn

Feb 23, 2025 Alivio Therapeutics (Launched by Puretech Health) is developing a novel technology for the targeted treatment of inflammatory disorders. The technology is based on a โ€ฆSee details»

Alivio Therapeutics - Craft

See insights on Alivio Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Alivio Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore Alivio Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 6 news, Drug:LYT-500, ALV-304, ALV-306, IMB-150.See details»

Alivio Therapeutics, Inc.:Company Profile & Technical Research ...

Alivio Therapeutics, Inc. is a company that provides Medicine, Immune system, Inflammation and more. Alivio Therapeutics, Inc. is headquartered in United States Massachusetts.See details»

Alivio Therapeutics - Products, Competitors, Financials, Employees ...

Alivio Therapeutics develops a novel strategy to treat inflammatory disorders through targeted disease immunomodulation and by selectively restoring immune homeostasis at inflamed sites โ€ฆSee details»

ALIVIO THERAPEUTICS INC Boston MA, 02210 - Company Profile

Free Business profile for ALIVIO THERAPEUTICS INC at 6 Tide St, Boston, MA, 02210-2412, US. ALIVIO THERAPEUTICS INC specializes in: Commercial Physical and Biological Research.See details»

Alivio Therapeutics Company Profile -Sales, Contacts, Competitors ...

Alivio Therapeutics is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for โ€ฆSee details»

Alivio Therapeutics | VentureRadar

Website: http://www.aliviotherapeutics.com/ Alivio is pioneering a novel strategy to treat inflammatory diseases based on modulating the immune system at the site of ...See details»

Alivio Therapeutics - Company Information, Competitors, News

Find useful insights on Alivio Therapeutics's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Alivio Therapeutics.See details»

Alivio Therapeutics - Contacts, Employees, Board Members

Alivio Therapeutics is pioneering a new way to treat inflammatory diseases based on precisely tuning the immune system.See details»

Nextsource | Company Profile | Alivio Therapeutics

Explore the company profile of Alivio Therapeutics (aliviotherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»

Alivio Therapeutics CEO, Founder, Key Executive Team, Board of ...

Aliviotherapeutics.com. Overview & Products; Financials; People; Executives 2. Board of Directors 2. Alivio Therapeutics Management Team2 Team Members. Alivio Therapeutics has 2 โ€ฆSee details»

PureTech Acquires Remaining Interest in Founded Entity Alivio ...

Jun 16, 2021 PureTech announced the acquisition of the remaining interest in its Founded Entity, Alivio Therapeutics. Alivioโ€™s therapeutic candidates, in development for inflammatory โ€ฆSee details»

Alivio Therapeutics | VentureRadar

Similar Companies: DelNova, Inc. USA n/a DelNova, Inc., is a therapeutics company focused on solving unmet medical needs using known drugs in combination with drug delivery expertise โ€ฆSee details»

Fresh from a new CAR-T biotech, PureTech launches Alivio โ€ฆ

May 10, 2016 Just one day after launching Vor BioPharma with some preclinical CAR-T tech licensed from Dr. Siddhartha Mukherjee, Bostonโ€™s VC-cum-research biotech has launched โ€ฆSee details»

PureTech buys out Alivio, adding inflammatory disease programs โ€ฆ

Jun 16, 2021 Four years after launching Alivio Therapeutics, PureTech Health is bringing the hydrogel player back into the fold by acquiring the remaining 22% of the company.See details»

linkstock.net © 2022. All rights reserved